We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
(-12%)
Cap. Flow
+$4.06B
Cap. Flow
% of AUM
5.93%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$124M |
| 2 |
Apple
AAPL
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Amazon
AMZN
|
+$71.3M |
| 5 |
Warner Bros
WBD
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
CERN
Cerner Corp
CERN
|
+$50.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$31.4M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$30.4M |
| 5 |
Yum China
YUMC
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGMS
2876
DELISTED
IGM Biosciences
IGMS
| $232K | ﹤0.01% |
12,883
+3,661
| +40% | +$65.3K |
|
|
NREF
2877
NexPoint Real Estate Finance
NREF
$342M
| $232K | ﹤0.01% |
+11,424
| New | +$262K |
|
2878
Tilly's
TLYS
$127M
| $230K | ﹤0.01% |
32,740
+4,085
| +14% | +$34.1K |
|
|
AKTS
2879
DELISTED
Akoustis Technologies Inc
AKTS
| $230K | ﹤0.01% |
62,250
+12,883
| +26% | +$57.1K |
|
|
AEFC
2880
Aegon Funding Co 5.10% Subordinated Notes due 2049
AEFC
$675M
| $229K | ﹤0.01% |
+10,900
| New | +$239K |
|
2881
BRC Inc
BRCC
$248M
| $228K | ﹤0.01% |
+27,935
| New | +$384K |
|
2882
Immunovant
IMVT
$8.13B
| $227K | ﹤0.01% |
58,175
+12,711
| +28% | +$54.9K |
|
2883
Public Storage 4.000% Series P Preferred Share
PSA.PRP
$369M
| $227K | ﹤0.01% |
+12,400
| New | +$233K |
|
2884
Palladyne AI
PDYN
$295M
| $227K | ﹤0.01% |
+14,220
| New | +$353K |
|
|
SNPO
2885
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $227K | ﹤0.01% |
24,793
+11,238
| +83% | +$136K |
|
|
VLTA
2886
DELISTED
Volta Inc.
VLTA
| $227K | ﹤0.01% |
+174,677
| New | +$390K |
|
2887
Atomera
ATOM
$209M
| $226K | ﹤0.01% |
24,127
+4,205
| +21% | +$46.3K |
|
|
CMRX
2888
DELISTED
Chimerix, Inc.
CMRX
| $226K | ﹤0.01% |
108,736
+9,225
| +9% | +$29.6K |
|
2889
Phathom Pharmaceuticals
PHAT
$677M
| $225K | ﹤0.01% |
26,649
+6,681
| +33% | +$68.7K |
|
2890
Tenaya Therapeutics
TNYA
$165M
| $225K | ﹤0.01% |
40,015
+17,217
| +76% | +$139K |
|
2891
Truist Financial Corp Series R Preferred Stock
TFC.PRR
$672M
| $224K | ﹤0.01% |
+11,200
| New | +$229K |
|
2892
Lifetime Brands
LCUT
$214M
| $223K | ﹤0.01% |
20,174
+3,601
| +22% | +$42.6K |
|
2893
Telephone and Data Systems Inc 6.625% Series UU Preferred Stock
TDS.PRU
$351M
| $221K | ﹤0.01% |
+10,900
| New | +$247K |
|
2894
Vera Therapeutics
VERA
$2.32B
| $221K | ﹤0.01% |
16,272
+5,887
| +57% | +$103K |
|
|
PAMT
2895
PAMT Corp
PAMT
$284M
| $221K | ﹤0.01% |
8,057
-3,068
| -28% | -$86.6K |
|
2896
Aemetis
AMTX
$121M
| $220K | ﹤0.01% |
44,757
+7,821
| +21% | +$68.4K |
|
2897
Concrete Pumping Holdings
BBCP
$489M
| $220K | ﹤0.01% |
36,313
+8,653
| +31% | +$49.1K |
|
2898
Focus Universal
FCUV
$3.74M
| $220K | ﹤0.01% |
+72
| New | +$246K |
|
2899
Ternium
TX
$10.6B
| $220K | ﹤0.01% |
+6,109
| New | +$260K |
|
2900
Weyco Group
WEYS
$434M
| $220K | ﹤0.01% |
+9,003
| New | +$243K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.
- RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
- RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
- RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
- RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
- RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
- RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.